Please note that a "1" following a contributor's name indicates that he or she has no relationships to disclose. A "2" indicates that the contributor has disclosed relationships. Please scroll down to view disclosures.
Richard S. Eisenstaedt, MD, FACP1
Clinical Professor of Medicine
Temple University School of Medicine
Chair, Department of Medicine
Abington Memorial Hospital
Abington, Pennsylvania
Jack Ende, MD, MACP1
Professor of Medicine
University of Pennsylvania School of Medicine
Chief, Department of Medicine
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
Thomas Fekete, MD, FACP1
Professor of Medicine
Associate Professor of Microbiology
Section of Infectious Diseases
Temple University Medical School
Philadelphia, Pennsylvania
Howard H. Weitz, MD, FACP1
Professor of Medicine
Director, Division of Cardiology
Vice-Chairman, Department of Medicine
Jefferson Medical College, Thomas Jefferson University
Philadelphia, Pennsylvania
D. Theresa Kanya, MBA1
Vice President, Medical Education Division
Sean McKinney1
Director
Self-Assessment Programs
Margaret Wells1
Managing Editor
Self-Assessment Programs
Valerie Dangovetsky1
Administrator
Self-Assessment Programs
Katie Idell1
Senior Staff Editor
Self-Assessment Programs
Becky Krumm1
Senior Staff Editor
Self-Assessment Programs
Ellen McDonald, PhD1
Senior Staff Editor
Self-Assessment Programs
Randy Hendrickson1
Production Administrator/Editor
Self-Assessment Programs
Megan Zborowski1
Staff Editor
Self-Assessment Programs
John Haefele1
Assistant Editor
Self-Assessment Programs
Developed by the American College of Physicians
The following contributors and ACP staff members have disclosed relationships with commercial companies:
Virginia U. Collier, MD, FACP
Stock Options/Holdings: Celgene, Pfizer, Merck, Schering Plough, Abbott, Johnson & Johnson, Medtronic, McKesson, Amgen
Mark A. Creager, MD
Research Grants/Contracts: Sanofi-Aventis, Merck
Consultantship: BioMarin, Genzyme, Itamar, NormOxys, Vascutek
Royalties: Elsevier, Springer
Other - Board Member: American Board of Vascular Medicine, Vascular Disease Foundation, American Heart Association
Stephanie Elkins, MD
Speakers Bureau: Cephalon Oncology, Celgene, GlaxoSmithKline
Thomas P. Olenginski, MD, FACP
Speakers Bureau: Wyeth-Pfizer, Amgen, Roche, Abbott, Novartis, Sanofi-Aventis, Procter & Gamble, Eli Lilly, Forest, Genzyme
Research Grants/Contracts: Roche, Eli Lilly, Veterans Administration
Richard S. Eisenstaedt, MD, FACP1
Clinical Professor of Medicine
Temple University School of Medicine
Chair, Department of Medicine
Abington Memorial Hospital
Abington, Pennsylvania
Jack Ende, MD, MACP1
Professor of Medicine
University of Pennsylvania School of Medicine
Chief, Department of Medicine
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
Thomas Fekete, MD, FACP1
Professor of Medicine
Associate Professor of Microbiology
Section of Infectious Diseases
Temple University Medical School
Philadelphia, Pennsylvania
Howard H. Weitz, MD, FACP1
Professor of Medicine
Director, Division of Cardiology
Vice-Chairman, Department of Medicine
Jefferson Medical College, Thomas Jefferson University
Philadelphia, Pennsylvania
D. Theresa Kanya, MBA1
Vice President, Medical Education Division
Sean McKinney1
Director
Self-Assessment Programs
Margaret Wells1
Managing Editor
Self-Assessment Programs
Valerie Dangovetsky1
Administrator
Self-Assessment Programs
Katie Idell1
Senior Staff Editor
Self-Assessment Programs
Becky Krumm1
Senior Staff Editor
Self-Assessment Programs
Ellen McDonald, PhD1
Senior Staff Editor
Self-Assessment Programs
Randy Hendrickson1
Production Administrator/Editor
Self-Assessment Programs
Megan Zborowski1
Staff Editor
Self-Assessment Programs
John Haefele1
Assistant Editor
Self-Assessment Programs
Linnea Donnarumma1
Assistant Editor
Self-Assessment Programs
Developed by the American College of Physicians
The following contributors and ACP staff members have disclosed relationships with commercial companies:
Virginia U. Collier, MD, FACP
Stock Options/Holdings: Celgene, Pfizer, Merck, Schering Plough, Abbott, Johnson & Johnson, Medtronic, McKesson, Amgen
Silvio E. Inzucchi, MD
Consultantship: Takeda, Merck, Amylin, Medtronic
Honoraria: NovoNordisk
Research Grants/Contracts: Boehringer-Ingelheim, Eli Lilly
Barbara Mathes, MD
Consultantship: Astellas, Johnson & Johnson
Michael Melia, MD
Other: Tibotec
Richard S. Eisenstaedt, MD, FACP1
Clinical Professor of Medicine
Temple University School of Medicine
Chair, Department of Medicine
Abington Memorial Hospital
Abington, Pennsylvania
Jack Ende, MD, MACP1
Professor of Medicine
University of Pennsylvania School of Medicine
Chief, Department of Medicine
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
Thomas Fekete, MD, FACP1
Professor of Medicine
Associate Professor of Microbiology
Section of Infectious Diseases
Temple University Medical School
Philadelphia, Pennsylvania
Howard H. Weitz, MD, FACP1
Professor of Medicine
Director, Division of Cardiology
Vice-Chairman, Department of Medicine
Jefferson Medical College, Thomas Jefferson University
Philadelphia, Pennsylvania
Patrick C. Alguire, MD, FACP1
Senior Vice President, Medical Education Division
D. Theresa Kanya, MBA1
Vice President, Medical Education Division
Sean McKinney1
Director
Self-Assessment Programs
Margaret Wells1
Managing Editor
Self-Assessment Programs
Katie Idell1
Senior Staff Editor
Self-Assessment Programs
Becky Krumm1
Senior Staff Editor
Self-Assessment Programs
Ellen McDonald, PhD1
Senior Staff Editor
Self-Assessment Programs
Randy Hendrickson1
Production Administrator/Editor
Self-Assessment Programs
Megan Zborowski1
Staff Editor
Self-Assessment Programs
Valerie Dangovetsky1
Administrator
Self-Assessment Programs
Linnea Donnarumma1
Assistant Editor
Self-Assessment Programs
John Haefele1
Assistant Editor
Self-Assessment Programs
Developed by the American College of Physicians
The following contributors and ACP staff members have disclosed relationships with commercial companies:
Brian Bosworth, MD
Stock Options/Holdings: Merck
Consultantship: Salix, Centocor Ortho Biotech Inc.
Virginia U. Collier, MD, FACP
Stock Options/Holdings: Celgene, Pfizer, Merck, Schering-Plough, Abbott, Johnson & Johnson, Medtronic, McKesson, Amgen
Mark A. Creager, MD
Research Grants/Contracts: Sanofi-Aventis, Merck
Consultantship: AstraZeneca, BioMarin, Genzyme, Itamar, Merck, NormOxys, Vascutek
Royalties: Elsevier, Springer
Board Member: American Board of Vascular Medicine, Vascular Disease Foundation, American Heart Association
Stephanie Elkins, MD
Speakers Bureau: Cephalon Oncology, Celgene, GlaxoSmithKline, Bristol-Myers Squibb
Thomas P. Olenginski, MD, FACP
Speakers Bureau: Wyeth-Pfizer, Amgen, Roche, Abbott, Novartis, Sanofi-Aventis, Procter & Gamble, Eli Lilly, Forest, Genzyme
Research Grants/Contracts: Roche, Eli Lilly, Veterans Administration
Consultantship: Eli Lilly, Amgen
Richard S. Eisenstaedt, MD, FACP1
Professor of Medicine
Temple University School of Medicine
Chair, Department of Medicine
Abington Memorial Hospital
Abington, Pennsylvania
Jack Ende, MD, MACP1
Professor of Medicine
University of Pennsylvania School of Medicine
Chief, Department of Medicine
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
Thomas Fekete, MD, FACP1
Professor of Medicine
Associate Professor of Microbiology
Section of Infectious Diseases
Temple University Medical School
Philadelphia, Pennsylvania
Howard H. Weitz, MD, FACP1
Professor of Medicine
Director, Division of Cardiology
Vice-Chairman, Department of Medicine
Jefferson Medical College, Thomas Jefferson University
Philadelphia, Pennsylvania
D. Theresa Kanya, MBA1
Vice President, Medical Education Division
Sean McKinney1
Director
Self-Assessment Programs
Margaret Wells1
Managing Editor
Self-Assessment Programs
Katie Idell1
Senior Staff Editor
Self-Assessment Programs
Becky Krumm1
Senior Staff Editor
Self-Assessment Programs
Ellen McDonald, PhD1
Senior Staff Editor
Self-Assessment Programs
Randy Hendrickson1
Production Administrator/Editor
Self-Assessment Programs
Megan Zborowski1
Staff Editor
Self-Assessment Programs
Valerie Dangovetsky1
Administrator
Self-Assessment Programs
Linnea Donnarumma1
Assistant Editor
Self-Assessment Programs
John Haefele1
Assistant Editor
Self-Assessment Programs
Developed by the American College of Physicians
The following contributors and ACP staff members have disclosed relationships with commercial companies:
Virginia U. Collier, MD, FACP
Stock Options/Holdings: Celgene, Pfizer, Merck, Schering Plough, Abbott, Johnson & Johnson, Medtronic, McKesson, Amgen
Henry S. Fraimow, MD
Research Grants/Contracts: JMI Laboratories, NIAID HIV/AIDS Clinical Trials Network, NIH, Epilepsy Research Foundation
Employment: Cooper University Hospital
Other: Epilepsy Study Consortium
John G. Park, MD
Research Grants/Contracts: Dymedix Corporation
Misha Rosenbach, MD
Research Grants/Contracts: Centocor, Johnson & Johnson
It is the policy of the American College of Physicians (ACP) to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. To this end, and consistent with the policies of the ACP and the Accreditation Council for Continuing Medical Education (ACCME), contributors to all ACP continuing medical education activities are required to disclose all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Contributors are required to use generic names in the discussion of therapeutic options and are required to identify any unapproved, off-label, or investigative use of commercial products or devices. Where a trade name is used, all available trade names for the same product type are also included. If trade-name products manufactured by companies with whom contributors have relationships are discussed, contributors are asked to provide evidence-based citations in support of the discussion. The information is reviewed by the MKSAP 15 Editor-in-Chief and Associate Editors. If necessary, adjustments to topics or contributors' roles in content development are made to balance the discussion. Further, all readers of this text are asked to evaluate the content for evidence of commercial bias so that future decisions about content and contributors can be made in light of this information.
Contributors' disclosure information can be found in Contributors and Conflict of Interest Disclosures.
To resolve all conflicts of interest and influences of vested interests, the ACP precluded members of the content-creation committee from deciding on any content issues that involved generic or trade-name products associated with proprietary entities with which these committee members had relationships. In addition, content was based on best evidence and updated clinical care guidelines when such evidence and guidelines were available.
Each of the four Updates allows you to earn up to 5 AMA PRA Category 1 Credits™.
The American Medical Association has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.
Credit for the July 2010 Update is available from July 31, 2010 to July 31, 2013.
Credit for the January 2011 Update is available from January 15, 2011 to January 15, 2014.
Credit for the July 2011 Update is available from July 31, 2011 to July 31, 2014.
Credit for the January 2012 Update is available from January 15, 2012 to January 15, 2015.
To earn CME credits, you must answer all of the provided questions, answering at least 33% of them correctly. When you have done so, go to the Answer Sheet, complete the identification form, and follow the instructions to complete your submission. You will receive confirmation of your submission on-screen and via email.
The American College of Physicians is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Physicians designates this enduring material, MKSAP 15 Updates, for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The learning objectives of MKSAP 15 Updates are to:
The editors and publisher of Medical Knowledge Self-Assessment Program 15 Update recognize that the development of new material offers many opportunities for error. Despite our best efforts, some errors may persist. Drug dosage schedules are, we believe, accurate and in accordance with current standards. Readers are advised, however, to ensure that the recommended dosages in the MKSAP 15 Updates concur with the information provided in the product information material. This is especially important in cases of new, infrequently used, or highly toxic drugs.
The primary purpose of the MKSAP 15 Updates is educational. Information presented, as well as publications, technologies, products, and/or services discussed, are intended to inform subscribers about the knowledge, techniques, and experiences of the contributors. A diversity of professional opinion exists, and the views of the contributors are their own and not those of the ACP. The ACP disclaims any and all liability for damages and claims, which may result from the use of information, publications, technologies, products, and/or services discussed in the MKSAP 15 Updates.
Copyright © 2011 American College of Physicians. All rights reserved.
This publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic or mechanical, including photocopy, without the express consent of the ACP.
Unauthorized reproduction of this publication is unlawful. The ACP prohibits reproduction of this publication in its entirety in any form either for individual use or for distribution. The ACP will consider granting an individual permission to reproduce only limited portions of this publication for his or her own exclusive use. Send requests in writing to MKSAP Permissions, American College of Physicians, 190 North Independence Mall West, Philadelphia, PA 19106-1572.
Published in the United States of America.